US ‘Stem cells regenerative medicine congress’ invites MEDIPOST for the first time as a Korean company2015/09/02STEM CELL THERAPEUTIC
MEDIPOST, achieves ‘150 patent applications and 50 patent registrations’2015/08/27STEM CELL THERAPEUTIC
Core dementia treatment technology patented at 6 European countries, concurrently2015/07/30STEM CELL THERAPEUTIC
‘CARTISTEM’ shows superb results from 3 year long term tracking clinical trials2015/07/23STEM CELL THERAPEUTIC
Lung disease medicine, ‘PNEUMOSTEM’ was designated as ‘Orphan Drug’ in Europe2015/07/06STEM CELL THERAPEUTIC
Participation in Biotec Japan and local publicity activities on CARTISTEM2015/05/13STEM CELL THERAPEUTIC
The only Korean company invited to North American Rare Medicine conference2015/04/24STEM CELL THERAPEUTIC
Administration of lung disease medicine ‘PNEUMOSTEM’ in clinical trial completed2015/04/15STEM CELL THERAPEUTIC
Administration of lung disease medicine ‘PNEUMOSTEM’ started in U.S. clinical trial2015/03/25STEM CELL THERAPEUTIC
